Close

Trevor Howe

Head, Translational Genomics, Johnson & Johnson Innovation, London

Trevor is Head of Translational Genomics at Johnson & Johnson Innovation EMEA and is located in the Innovation Center in London. His area of focus is to identify partnerships and collaborations to show where a demonstrable human genetic signature can be tested and applied into a pathway or network. There is increasing recognition that where such signatures are built into projects they are far more likely to progress to be viable treatments and solutions for patients.

Most recently Trevor was involved in a team negotiating Johnson & Johnson’s participation to execute whole genome sequencing on the entire UK BioBank. He also established the Phenomics Discovery Initiative in partnership with UK National Phenotypic Screening Centre, which works to accelerate the translation of novel biology into therapeutics.

Previously Trevor was Head of Molecular Informatics at Janssen in Beerse, Belgium, leading a group of computational chemists, biologists and structural biologists. Prior to this Trevor was at Novartis where he was Worldwide Head of Computational Chemistry. Immediately from his postdoc he established the computational and cheminformatics function for Lilly UK.

Trevor studied Chemistry and Physical Organic Chemistry at the Universities of Exeter and East Anglia in the UK, followed by postdocs at State University of New York in Buffalo, USA and University of Oxford in the UK.

Trevor Howe
Trevor Howe